Self-Assessment of eresearch Compliance with 21 CFR Part 11, Electronic Record; Electronic Signatures
|
|
|
- Beatrice Cross
- 10 years ago
- Views:
Transcription
1 Self-Assessment of eresearch Compliance with 21 CFR Part 11, Electronic Record; Electronic Signatures Subpart A General Provisions Sec Scope. (a) The regulations in this part set forth the criteria under which the agency considers electronic records, electronic signatures, and handwritten signatures executed to electronic records to be trustworthy, reliable, and generally equivalent to paper records and handwritten signatures executed on paper. (b) This part applies to records in electronic form that are created, modified, maintained, archived, retrieved, or transmitted, under any records requirements set forth in agency regulations. This part also applies to electronic records submitted to the agency under requirements of the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act, even if such records are not specifically identified in agency regulations. However, this part does not apply to paper records that are, or have been, transmitted by electronic means. (c) Where electronic signatures and their associated electronic records meet the requirements of this part, the agency will consider the electronic signatures to be equivalent to full handwritten signatures, initials, and other general signings as required by agency regulations, unless specifically excepted by regulation(s) effective on or after August 20, (d) Electronic records that meet the requirements of this part may be used in lieu of paper records, in accordance with 11.2, unless paper records are specifically required. (e) Computer systems (including hardware and software), controls, and attendant documentation maintained under this part shall be readily available for, and subject to, FDA inspection. (f) This part does not apply to records required to be established or maintained by through of this chapter. Records that satisfy the requirements of part 1, subpart J of this chapter, but that also are required under other applicable statutory provisions or regulations, remain subject to this part. Sec Implementation. (a) For records required to be maintained but not submitted to the agency, persons may use electronic records in lieu of paper records or electronic signatures in lieu of traditional signatures, in whole or in part, provided that the requirements of this part are met. (b) For records submitted to the agency, persons may use electronic records in lieu of paper records or electronic signatures in lieu of traditional signatures, in whole or in part, provided that: (1) The requirements of this part are met; and (2) The document or parts of a document to be submitted have been identified in public docket No. 92S-0251 as being the type of submission the agency accepts in electronic form. This docket will identify specifically what types of documents or parts of documents are acceptable for submission in electronic form without paper records and the agency receiving unit(s) (e.g., specific center, office, division, branch) to which such submissions may be made. Documents to agency receiving unit(s) not specified in the public docket will not be considered as official if they are submitted in electronic form; paper forms of such documents will be considered as official and must accompany any electronic records. Persons are expected to consult with the intended agency receiving unit for details on how (e.g.,
2 method of transmission, media, file formats, and technical protocols) and whether to proceed with the electronic submission. Sec Definitions. (a) The definitions and interpretations of terms contained in section 201 of the act apply to those terms when used in this part. (b) The following definitions of terms also apply to this part: 393)). (1) Act means the Federal Food, Drug, and Cosmetic Act (secs (21 U.S.C (2) Agency means the Food and Drug Administration. (3) Biometrics means a method of verifying an individual's identity based on measurement of the individual's physical feature(s) or repeatable action(s) where those features and/or actions are both unique to that individual and measurable. (4) Closed system means an environment in which system access is controlled by persons who are responsible for the content of electronic records that are on the system. (5) Digital signature means an electronic signature based upon cryptographic methods of originator authentication, computed by using a set of rules and a set of parameters such that the identity of the signer and the integrity of the data can be verified. (6) Electronic record means any combination of text, graphics, data, audio, pictorial, or other information representation in digital form that is created, modified, maintained, archived, retrieved, or distributed by a computer system. (7) Electronic signature means a computer data compilation of any symbol or series of symbols executed, adopted, or authorized by an individual to be the legally binding equivalent of the individual's handwritten signature. (8) Handwritten signature means the scripted name or legal mark of an individual handwritten by that individual and executed or adopted with the present intention to authenticate a writing in a permanent form. The act of signing with a writing or marking instrument such as a pen or stylus is preserved. The scripted name or legal mark, while conventionally applied to paper, may also be applied to other devices that capture the name or mark. (9) Open system means an environment in which system access is not controlled by persons who are responsible for the content of electronic records that are on the system. Subpart B Electronic Records Sec Controls for closed systems. Persons who use closed systems to create, modify, maintain, or transmit electronic records shall employ procedures and controls designed to ensure the authenticity, integrity, and, when appropriate, the confidentiality of electronic records, and to ensure that the signer cannot readily repudiate the signed record as not genuine. Such procedures and controls shall include the following: (a) Validation of systems to ensure accuracy, reliability, consistent intended performance, and the ability to discern invalid or altered records.
3 eresearch is configured to track all changes made to the form set after the initial submission for review. Business process steps are fully recorded in activity log audit that includes a complete record of all data changes with a stamp of the user that completed the activity and a date and timestamp on the activity. (b) The ability to generate accurate and complete copies of records in both human readable and electronic form suitable for inspection, review, and copying by the agency. Persons should contact the agency if there are any questions regarding the ability of the agency to perform such review and copying of the electronic records. eresearch allow both the electronic review of all material as well as the ability to print or save to disk all of the information. (c) Protection of records to enable their accurate and ready retrieval throughout the records retention period. All records are currently retained because we have not reached the retention period because the system is too new. Archiving policies will be sent to general counsel to review before being implemented to ensure they are compliant. (d) Limiting system access to authorized individuals. A user needs to be explicitly named as a study team member to view information. Staff and Reviewers access is added through an access request process through the MAIS help desk. (e) Use of secure, computer-generated, time-stamped audit trails to independently record the date and time of operator entries and actions that create, modify, or delete electronic records. Record changes shall not obscure previously recorded information. Such audit trail documentation shall be retained for a period at least as long as that required for the subject electronic records and shall be available for agency review and copying. All activities and changes are logged and time-stamped and are part of the electronic record. A purge function for the activity log does not exist in the system, even for administrators. (f) Use of operational system checks to enforce permitted sequencing of steps and events, as appropriate. Process is programmed and limited to specific processing steps. All moves between business process steps are logged as activities for full audit. Steps limited based on defined business process. (g) Use of authority checks to ensure that only authorized individuals can use the system, electronically sign a record, access the operation or computer system input or output device, alter a record, or perform the operation at hand. Only a limited set of IRB super users (Managers and Directors) are authorized to set signatures of IRB Chairs on IRB approval letters. Reviewers are added through access
4 request and are assigned to review specific studies. PI, Co-Is and Faculty Advisors are set per study. (h) Use of device (e.g., terminal) checks to determine, as appropriate, the validity of the source of data input or operational instruction. Every transaction is logged in eresearch with the login ID. (i) Determination that persons who develop, maintain, or use electronic record/electronic signature systems have the education, training, and experience to perform their assigned tasks. Training is provided for all new reviewers. Checkbox for PIs are used to attest they understand what they are signing. On-line training for all study team members and help desk support to help all users perform tasks. (j) The establishment of, and adherence to, written policies that hold individuals accountable and responsible for actions initiated under their electronic signatures, in order to deter record and signature falsification. SPG : Delegation of Authority to Bind the University SPG : Proper Use of Information Resources SPG : Identity Misrepresentation ITCS Responsible Use Guidelines (k) Use of appropriate controls over systems documentation including: (1) Adequate controls over the distribution of, access to, and use of documentation for system operation and maintenance. (2) Revision and change control procedures to maintain an audit trail that documents time-sequenced development and modification of systems documentation. We have full audit trail of all changes to the system, including code source control and migration documentation and change control for any changes to production environment. Sec Controls for open systems. [N/A] Persons who use open systems to create, modify, maintain, or transmit electronic records shall employ procedures and controls designed to ensure the authenticity, integrity, and, as appropriate, the confidentiality of electronic records from the point of their creation to the point of their receipt. Such procedures and controls shall include those identified in 11.10, as appropriate, and additional measures such as document encryption and use of appropriate digital signature standards to ensure, as necessary under the circumstances, record authenticity, integrity, and confidentiality. Sec Signature manifestations. (a) Signed electronic records shall contain information associated with the signing that clearly indicates all of the following: (1) The printed name of the signer;
5 (2) The date and time when the signature was executed; and the signature. (3) The meaning (such as review, approval, responsibility, or authorship) associated with We have an audit trail on activities for 1 and 2. We have an attestation on events with checking of box for 3. (b) The items identified in paragraphs (a)(1), (a)(2), and (a)(3) of this section shall be subject to the same controls as for electronic records and shall be included as part of any human readable form of the electronic record (such as electronic display or printout). IRB approval letters have date and name of signature authority and explanation of approval. Sec Signature/record linking. Electronic signatures and handwritten signatures executed to electronic records shall be linked to their respective electronic records to ensure that the signatures cannot be excised, copied, or otherwise transferred to falsify an electronic record by ordinary means. It is not possible to alter the approval letters within eresearch. Subpart C Electronic Signatures Sec General requirements. (a) Each electronic signature shall be unique to one individual and shall not be reused by, or reassigned to, anyone else. UM IDs are not reassigned (b) Before an organization establishes, assigns, certifies, or otherwise sanctions an individual's electronic signature, or any element of such electronic signature, the organization shall verify the identity of the individual. The identity of UM employees is verified at the time unique names and passwords are assigned. Investigators and study team members who are not UM employees may register for a friends account to obtain access to the eresearch system. IRB staff will verify the identity of non-um employees applying to serve as principal investigators. For non-um employees serving as co-investigators, faculty mentors, or study team members, the principal investigator has the responsibility of verifying the identity of these individuals. The PI may delegate this responsibility to the study coordinator. (c) Persons using electronic signatures shall, prior to or at the time of such use, certify to the agency that the electronic signatures in their system, used on or after August 20, 1997, are intended to be the legally binding equivalent of traditional handwritten signatures. (1) The certification shall be submitted in paper form and signed with a traditional handwritten signature, to the Office of Regional Operations (HFC-100), 5600 Fishers Lane, Rockville, MD
6 (2) Persons using electronic signatures shall, upon agency request, provide additional certification or testimony that a specific electronic signature is the legally binding equivalent of the signer's handwritten signature. Letter sent to FDA 07/15/08. Sec Electronic signature components and controls. (a) Electronic signatures that are not based upon biometrics shall: and password. (1) Employ at least two distinct identification components such as an identification code (i) When an individual executes a series of signings during a single, continuous period of controlled system access, the first signing shall be executed using all electronic signature components; subsequent signings shall be executed using at least one electronic signature component that is only executable by, and designed to be used only by, the individual. (ii) When an individual executes one or more signings not performed during a single, continuous period of controlled system access, each signing shall be executed using all of the electronic signature components. (2) Be used only by their genuine owners; and (3) Be administered and executed to ensure that attempted use of an individual's electronic signature by anyone other than its genuine owner requires collaboration of two or more individuals. Met with UM ID and password plus newly added certification. (b) Electronic signatures based upon biometrics shall be designed to ensure that they cannot be used by anyone other than their genuine owners. Sec Controls for identification codes/passwords. Persons who use electronic signatures based upon use of identification codes in combination with passwords shall employ controls to ensure their security and integrity. Such controls shall include: (a) Maintaining the uniqueness of each combined identification code and password, such that no two individuals have the same combination of identification code and password. UM ID is unique. (b) Ensuring that identification code and password issuances are periodically checked, recalled, or revised (e.g., to cover such events as password aging). Currently, passwords must be changed every 10 years, but by next year faculty will be required to use an M-token that would tighten this procedure. (c) Following loss management procedures to electronically deauthorize lost, stolen, missing, or otherwise potentially compromised tokens, cards, and other devices that bear or generate identification
7 code or password information, and to issue temporary or permanent replacements using suitable, rigorous controls. Current resets of password would meet this control given that is requires answering question and access to account previously identified with account. (d) Use of transaction safeguards to prevent unauthorized use of passwords and/or identification codes, and to detect and report in an immediate and urgent manner any attempts at their unauthorized use to the system security unit, and, as appropriate, to organizational management. An intruder lockout is in place. (e) Initial and periodic testing of devices, such as tokens or cards, that bear or generate identification code or password information to ensure that they function properly and have not been altered in an unauthorized manner. In place with M-token.
Implementation of 21CFR11 Features in Micromeritics Software Software ID
Implementation of 21CFR11 Features in Micromeritics Software Software ID PART 11 ELECTRONIC RECORDS; ELECTRONIC SIGNATURES Subpart A General Provisions Sec. 11.1 Scope. 11.2 Implementation. 11.3 Definitions.
21 CFR PART 11 ELECTRONIC RECORDS, ELECTRONIC SIGNATURES 21.11.2013. 21 CFR Part 11 Compliance PLA 2.1
21 CFR PART 11 ELECTRONIC RECORDS, ELECTRONIC SIGNATURES Compliance of PLA 2.1 21.11.2013 21 CFR Part 11 Compliance PLA 2.1 SEC. 11.2 IMPLEMENTATION. (a) For records required to be maintained but not submitted
InfinityQS SPC Quality System & FDA s 21 CFR Part 11 Requirements
InfinityQS SPC Quality System & FDA s 21 CFR Part 11 Requirements www.infinityqs.com Copyright InfinityQS International Table of Contents Overview... FDA s 21 CFR Part 11 Requirements... PART 11 ELECTRONIC
Electronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device industries
White Paper No 01 I December 2010 Implementation of 21 CFR Part 11 in the epmotion Software Electronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device
The Impact of 21 CFR Part 11 on Product Development
The Impact of 21 CFR Part 11 on Product Development Product development has become an increasingly critical factor in highly-regulated life sciences industries. Biotechnology, medical device, and pharmaceutical
21 CFR Part 11 Implementation Spectrum ES
21 CFR Part 11 Implementation Spectrum ES INFRARED SPECTROSCOPY T E C H N I C A L N O T E Introduction Compliance with 21 CFR Part 11 is mandatory for pharmaceutical companies and their suppliers to sell
Compliance Matrix for 21 CFR Part 11: Electronic Records
Compliance Matrix for 21 CFR Part 11: Electronic Records Philip E. Plantz, PhD, Applications Manager David Kremer, Senior Software Engineer Application Note SL-AN-27 Revision A Provided By: Microtrac,
FILEHOLD DOCUMENT MANAGEMENT SYSTEM 21 CFR PART 11 COMPLIANCE WHITE PAPER
FILEHOLD DOCUMENT MANAGEMENT SYSTEM 21 CFR PART 11 COMPLIANCE WHITE PAPER Copyright 2012 FileHold Systems Inc. All rights reserved. For further information about this manual or other FileHold Systems products,
POLICY ISSUES IN E-COMMERCE APPLICATIONS: ELECTRONIC RECORD AND SIGNATURE COMPLIANCE FDA 21 CFR 11 ALPHATRUST PRONTO ENTERPRISE PLATFORM
W H I T E P A P E R POLICY ISSUES IN E-COMMERCE APPLICATIONS: ELECTRONIC RECORD AND SIGNATURE COMPLIANCE FDA 21 CFR 11 ALPHATRUST PRONTO ENTERPRISE PLATFORM This white paper is written for senior executives
FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997)
www.qadata.co.za Introduction FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997) INITIAL REGULATION RELEASED High profile audit findings Industry complaints to wasting
rsdm and 21 CFR Part 11
rsdm and 21 CFR Part 11 Meeting the 21 CFR Part 11 Burden without Overburdening The right solutions for smaller biopharma. Nothing more. Nothing less. Prepared by: Ken VanLuvanee www.virtualregulatorysolutions.com
A ChemoMetec A/S White Paper September 2013
NucleoCounter NC-3000, NucleoView NC-3000 Software and Code of Federal Regulation 21 Part 11; Electronic Records, Electronic Signatures (21 CFR Part 11) A ChemoMetec A/S White Paper September 2013 ChemoMetec
Oracle WebCenter Content
Oracle WebCenter Content 21 CFR Part 11 Certification Kim Hutchings US Data Management Phone: 888-231-0816 Email: [email protected] Introduction In May 2011, US Data Management (USDM) was
Assessment of Vaisala Veriteq vlog Validation System Compliance to 21 CFR Part 11 Requirements
/ WHITE PAPER Assessment of Vaisala Veriteq vlog Validation System Compliance to 21 CFR Part 11 Requirements The 21 CFR Part 11 rule states that the FDA view is that the risks of falsification, misinterpretation,
Implement best practices by using FileMaker Pro 7 as the backbone of your 21 CFR 11 compliant system.
21 CRF 11 Electronic Records and Signatures Implement best practices by using FileMaker Pro 7 as the backbone of your 21 CFR 11 compliant system. By Todd Duell What does Title 21 of the Code of Federal
Enabling SharePoint for 21 CFR Part 11 Compliance - Electronic Signature Use Case
Enabling SharePoint for 21 CFR Part 11 Compliance - Electronic Signature Use Case Sudeep Nambiar Technical Strategist www.linkedin.com/in/sudeepnambiar/ Thanks to our Sponsors! Platinum: Gold: Silver:
SolidWorks Enterprise PDM and FDA 21CFR Part 11
T E C H N I C A L P A P E R SolidWorks Enterprise PDM and FDA 21CFR Part 11 This Technical Paper discusses the technical solutions provided by SolidWorks Enterprise PDM to address the FDA 21 CFR Part 11
InfoCenter Suite and the FDA s 21 CFR part 11 Electronic Records; Electronic Signatures
InfoCenter Suite and the FDA s 21 CFR part 11 Electronic Records; Electronic Signatures Overview One of the most popular applications of InfoCenter Suite is to help FDA regulated companies comply with
Full Compliance Contents
Full Compliance for and EU Annex 11 With the regulation support of Contents 1. Introduction 2 2. The regulations 2 3. FDA 3 Subpart B Electronic records 3 Subpart C Electronic Signatures 9 4. EU GMP Annex
21 CFR Part 11 White Paper
21 CFR Part 11 White Paper Version V8.00 SR1 ProLeiT AG Einsteinstrasse 8, D-91074 Herzogenaurach, Germany Phone: +49 (0) 9132 777-0 Fax: +49 (0) 9132 777-150 E-Mail: [email protected] Internet: http://www.proleit.com
How To Control A Record System
Thermo Scientific Qtegra Intelligent Scientific Data Solution (ISDS) Software for 21 CFR Part 11 Compliant Laboratories Technical Note 43106 Key Words Compliance, Electronic Records, 21 CFR Part 11 Goal
DeltaV Capabilities for Electronic Records Management
January 2013 Page 1 DeltaV Capabilities for Electronic Records Management This paper describes DeltaV s integrated solution for meeting FDA 21CFR Part 11 requirements in process automation applications
FDA 21 CFR Part 11 Electronic records and signatures solutions for the Life Sciences Industry
FDA 21 CFR Part 11 Electronic records and signatures solutions for the Life Sciences Industry The Rule 21 CFR Part 11 Handwritten signature means the scripted name or legal mark of an individual handwritten
Tools to Aid in 21 CFR Part 11 Compliance with EZChrom Elite Chromatography Data System. White Paper. By Frank Tontala
Tools to Aid in 21 CFR Part 11 Compliance with EZChrom Elite Chromatography Data System White Paper By Frank Tontala Agilent Technologies Software & Informatics Life Sciences & Chemical Analysis Group
21 CFR Part 11 Checklist
21 CFR Part 11 Checklist GUIDE NOTOCORD - 113 Chemin de Ronde - 78290 Croissy-sur-Seine www.notocord.com my.notocord.com [email protected] +33 (0)1 34 80 00 00 1. Preliminary information 1.1. Purpose
Intland s Medical Template
Intland s Medical Template Traceability Browser Risk Management & FMEA Medical Wiki Supports compliance with IEC 62304, FDA Title 21 CFR Part 11, ISO 14971, IEC 60601 and more INTLAND codebeamer ALM is
AutoSave. Achieving Part 11 Compliance. A White Paper
AutoSave Achieving Part 11 Compliance A White Paper Synopsis This whitepaper provides information related to FDA regulation 21 CFR Part 11 (Part 11) for organizations considering MDT software solutions.
Agilent MicroLab Software with Spectroscopy Configuration Manager and Spectroscopy Database Administrator (SCM/SDA)
Agilent MicroLab Software with Spectroscopy Configuration Manager and Spectroscopy Database Administrator (SCM/SDA) Compliance with 21 CFR Part 11 Introduction Part 11 in Title 21 of the Code of Federal
Implementing CitectSCADA to meet the requirements of FDA 21 CFR Part 11
Implementing CitectSCADA to meet the requirements of FDA 21 CFR Part 11 Version 2.0 July 2008 FDA 21 CFR Part 11 READY Reversed out on solid background colour Background In 1991, members of the pharmaceutical
DeltaV Capabilities for Electronic Records Management
September 2004 Page 1 An integrated solution for meeting FDA 21CFR Part 11 requirements in process automation applications using a configurable off-the-shelf (COTS) solution Emerson Process Management.
21 CFR Part 11 Electronic Records & Signatures
Gap Analysis - Checklist 21 CFR Part 11 Electronic Records & Signatures his document is a proposal and starting point only. he type and extent of documentation depends on the process environment. he proposed
Empower TM 2 Software
Empower TM 2 Software 21 CFR PART 11 COMPLIANCE ASSESSMENT Revision A, December, 2005 1 of 14 Waters Corporation Note: Information presented in this document assumes that the appropriate Empower 2 System
Meeting the FDA s Requirements for Electronic Records and Electronic Signatures (21 CFR Part 11)
Meeting the FDA s Requirements for Electronic Records and Electronic Signatures (21 CFR Part 11) Executive Summary...3 Background...4 Internet Growth in the Pharmaceutical Industries...4 The Need for Security...4
21 CFR Part 11 Deployment Guide for Wonderware System Platform 3.1, InTouch 10.1 and Historian 9.0
Deployment Guide 21 CFR Part 11 Deployment Guide for Authors: Invensys Operations Management and TSD (Total System Design, an Optimation Company) Table of Contents by Section 1 Before you Begin...............................................................................................
Software Manual Part IV: FDA 21 CFR part 11. Version 2.20
Software Manual Part IV: FDA 21 CFR part 11 Version 2.20 OPTIMA Software Manual Part IV: FDA 21 CFR part 11 BMG LABTECH This manual was designed to guide OPTIMA users through the software features related
21 CFR Part 11 Compliance Using STATISTICA
21 CFR Part 11 Compliance Using STATISTICA Last Updated: April 2003 This document was updated to reflect the FDA s latest guidance (released February, 2003) and the withdrawal of previous guidance.! STATSOFT
Implementing Title 21 CFR Part 11 (Electronic Records ; Electronic Signatures) in Manufacturing Presented by: Steve Malyszko, P.E.
Implementing Title 21 CFR Part 11 (Electronic Records ; Electronic Signatures) in Manufacturing Presented by: Steve Malyszko, P.E. President & CEO Agenda Introduction Who is Malisko Engineering? Title
Using the Thermo Scientific Dionex Chromeleon 7 Chromatography Data System (CDS) to Comply with 21 CFR Part 11. Compliance Guide
Using the Thermo Scientific Dionex Chromeleon 7 Chromatography Data System (CDS) to Comply with 21 CFR Part 11 Compliance Guide Table of Contents Introduction... 3 PART 11 ELECTRONIC RECORDS; ELECTRONIC
Compliance Response Edition 07/2009. SIMATIC WinCC V7.0 Compliance Response Electronic Records / Electronic Signatures. simatic wincc DOKUMENTATION
Compliance Response Edition 07/2009 SIMATIC WinCC V7.0 Compliance Response Electronic Records / Electronic Signatures simatic wincc DOKUMENTATION Compliance Response Electronic Records / Electronic Signatures
Compliance in the BioPharma Industry. White Paper v1.0
in the BioPharma Industry White Paper v1.0 July 2005 I. Introduction...3 II. Overview of Regulations...3 III. Overview of Validation...4 a. Validation...4 b. Security s Part Within Validation...6 IV. Introduction
ScreenMaster RVG200 Paperless recorder FDA-approved record keeping. Measurement made easy
Information INF13/147 EN ScreenMaster RVG200 Paperless recorder FDA-approved record keeping Measurement made easy Guidance on the use of the RVG200 paperless recorder for electronic record keeping in FDA-approved
Using Chromeleon Chromatography Management Software to Comply with 21 CFR Part 11
Technical Note 54 Using Chromeleon Chromatography Management Software to Comply with 21 CFR Part 11 The Electronic Records and Signatures Rule 1, known as 21 CFR Part 11, was established by the U.S. Food
For technical assistance, please contact: Thermo Nicolet Corporation 5225 Verona Road Madison WI 53711-4495
The information in this publication is provided for reference only. All information contained in this publication is believed to be correct and complete. Thermo Nicolet Corporation shall not be liable
Guidance for Industry. 21 CFR Part 11; Electronic. Records; Electronic Signatures. Time Stamps
Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures Time Stamps Draft Guidance This guidance document is being distributed for comment purposes only. Comments and suggestions
Declaration of Conformity 21 CFR Part 11 SIMATIC WinCC flexible 2007
Declaration of Conformity 21 CFR Part 11 SIMATIC WinCC flexible 2007 SIEMENS AG Industry Sector Industry Automation D-76181 Karlsruhe, Federal Republic of Germany E-mail: [email protected] Fax: +49
Thermal Analysis. http://www.fda.gov. Subpart A General Provisions 11.1 Scope. 11.2 Implementation. 11.3 Definitions.
Thermal Analysis 21 CFR 11 Compliance 21 CFR Part 11 Electronic Records; Electronic Signatures General concept The U.S. Federal Food and Drug Administration (FDA) has issued regulations that provide criteria
Guidance for Industry. 21 CFR Part 11; Electronic Records; Electronic Signatures. Electronic Copies of Electronic Records
Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures Electronic Copies of Electronic Records Draft Guidance This guidance document is being distributed for comment purposes only.
Electronic Document and Record Compliance for the Life Sciences
Electronic Document and Record Compliance for the Life Sciences Kiran Thakrar, SoluSoft Inc. SoluSoft, Inc. 300 Willow Street South North Andover, MA 01845 Website: www.solu-soft.com Email: [email protected]
Nova Southeastern University Standard Operating Procedure for GCP. Title: Electronic Source Documents for Clinical Research Study Version # 1
Nova Southeastern University Standard Operating Procedure for GCP Title: Electronic Source Documents for Clinical Research Study Version # 1 SOP Number: OCR-RDM-006 Effective Date: August 2013 Page 1 of
Guidance for Industry. 21 CFR Part 11; Electronic Records; Electronic Signatures. Maintenance of Electronic Records
Draft Guidance for Industry -- Not For Implementation Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures Maintenance of Electronic Records Draft Guidance This guidance document
Compliance Response SIMATIC SIMATIC PCS 7 V8.1. Electronic Records / Electronic Signatures (ERES) Edition 03/2015. Answers for industry.
SIMATIC SIMATIC PCS 7 V8.1 Electronic Records / Electronic Signatures (ERES) Compliance Response Edition 03/2015 Answers for industry. Compliance Response Electronic Records / Electronic Signatures (ERES)
Achieving 21 CFR Part 11 Compliance with Appian
Achieving 21 CFR Part 11 Compliance with Appian Executive Summary Software performance in the life sciences industry has extremely high standards. The FDA and other regulatory bodies require software used
Data Management PACT Workshop: Design & Operation of GMP Cell Therapy Facilities April 10 th -11 th, 2007
Data Management PACT Workshop: Design & Operation of GMP Cell Therapy Facilities April 10 th -11 th, 2007 Data Management Discuss Database Development Design Process Tips Data Normalization Reporting Ideas
Software. For the 21 CFR Part 11 Environment. The Science and Technology of Small Particles
Software For the 21 CFR Part 11 Environment The Science and Technology of Small Particles 21 CFR Part 11 Solution confirm Software The Code of Federal Regulations Title 21, Part 11, was implemented by
Waters Empower 2 Software Seamlessly Manages Regulated Data to Aid in 21 CFR Part 11 Compliance
THE ROLE OF WATERS EMPOWER 2 SOFTWARE IN ASSISTING IN 21 CFR PART 11 COMPLIANCE Waters Empower 2 Software Seamlessly Manages Regulated Data to Aid in 21 CFR Part 11 Compliance Summary The objective of
Spectroscopy Configuration Manager (SCM) Software. 21 CFR Part 11 Compliance Booklet
Spectroscopy Configuration Manager (SCM) Software 21 CFR Part 11 Compliance Booklet Notices Agilent Technologies, Inc. 2015 No part of this manual may be reproduced in any form or by any means (including
Electronic Records and Signatures: Compliance with Title 21 CFR Part 11 Requirements
Electronic Records and Signatures: Compliance with Title 21 CFR Part 11 Requirements Version 4.5. June 2015 Contents 1 Introduction... 3 2 Definitions (21 CFR Part 11: para 11.3)... 3 3 Administrative
Waters Empower Software Seamlessly Manages Regulated Data to Aid in 21 CFR Part 11 Compliance
THE ROLE OF WATERS EMPOWER SOFTWARE IN ASSISTING IN 21 CFR PART 11 COMPLIANCE Waters Empower Software Seamlessly Manages Regulated Data to Aid in 21 CFR Part 11 Compliance Summary The objective of this
Considerations for validating SDS Software v2.x Enterprise Edition for the 7900HT Fast Real-Time PCR System per the GAMP 5 guide
WHITE PAPER SDS Software v2.x Enterprise Edition Considerations for validating SDS Software v2.x Enterprise Edition for the 7900HT Fast Real-Time PCR System per the GAMP 5 guide This white paper describes
Good Electronic Records Management (GERM) Using IBM Rational ClearCase and IBM Rational ClearQuest
A technical discussion of Good Electronic Records Management using Rational software from IBM 04/03 Good Electronic Records Management (GERM) Using IBM Rational ClearCase and IBM Rational ClearQuest Matthew
Life sciences solutions compliant with FDA 21 CFR Part 11
Life sciences solutions compliant with FDA 21 CFR Part 11 System 800xA facilitates regulatory compliance As part of ABB s strategy we have invested considerably in the development of advanced solutions
Guidance for Industry COMPUTERIZED SYSTEMS USED IN CLINICAL TRIALS
Guidance for Industry COMPUTERIZED SYSTEMS USED IN CLINICAL TRIALS U.S. Department of Health and Human Services Food and Drug Administration Center for Biologic Evaluation and Research (CBER) Center for
Supplement to the Guidance for Electronic Data Capture in Clinical Trials
Supplement to the Guidance for Electronic Data Capture in Clinical Trials January 10, 2012 Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Note: The original language of this
Sympatec GmbH System-Partikel-Technik WINDOX 4. Electronic Records/ Electronic Signatures Compliance Assessment Worksheet for 21 CFR Part 11
Sympatec GmbH System-Partikel-Technik WINDOX 4 Electronic Records/ Electronic Signatures Compliance Worksheet for 21 CFR Part 11 Note Complete or partial duplication of the present documentation and
Guidance for Industry
Guidance for Industry Electronic Source Data in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for
TIBCO Spotfire and S+ Product Family
TIBCO Spotfire and S+ Product Family Compliance with 21 CFR Part 11, GxP and Related Software Validation Issues The Code of Federal Regulations Title 21 Part 11 is a significant regulatory requirement
Guidance for Industry
Guidance for Industry Electronic Source Data in Clinical Investigations DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft
Guidance for Industry Computerized Systems Used in Clinical Investigations
Guidance for Industry Computerized Systems Used in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration (FDA) Office of the Commissioner (OC) May 2007 Guidance
THE ROLE OF WATERS NUGENESIS SDMS IN 21 CFR PART 11 COMPLIANCE
THE ROLE OF WATERS NUGENESIS SDMS IN 21 CFR PART 11 COMPLIANCE The objective of this article is to discuss the 21 CFR Part 11 compliance utility of the Waters NuGenesis Scientific Data Management System
21 CFR Part 11 LIMS Requirements Electronic signatures and records
21 CFR Part 11 LIMS Requirements Electronic signatures and records Compiled by Perry W. Burton. Version 1.4, 8 Sept 2014 Table of contents 1. Purpose of this document 1 1.1 Notes to version 1.4 1 1.2 About
Manual 074 Electronic Records and Electronic Signatures 1. Purpose
1. Purpose The purpose of this document is to provide an interpretation of FDA 21 CFR Part 11, Electronic Records; Electronic Signatures (ER/ES) and to provide guidance for acceptable practices in the
Eclipsys Sunrise Clinical Manager Enterprise Electronic Medical Record (SCM) and Title 21 Code of Federal Regulations Part 11 (21CFR11)
Eclipsys Sunrise Clinical Manager Enterprise Electronic Medical Record (SCM) and Title 21 Code of Federal Regulations Part 11 (21CFR11) The title 21 code of federal regulations part 11 deals with an institutions
A unique biometrics based identifier, such as a fingerprint, voice print, or a retinal scan; or
SBA Procedural Notice TO: All SBA Employees CONTROL NO.: 5000-1323 SUBJECT: Acceptance of Electronic Signatures in the 7(a) and 504 Loan Program EFFECTIVE: 10/21/14 The purpose of this Notice is to inform
January 30, 2014 Mortgagee Letter 2014-03
U.S. DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT WASHINGTON, DC 20410-8000 ASSISTANT SECRETARY FOR HOUSING- FEDERAL HOUSING COMMISSIONER January 30, 2014 Mortgagee Letter 2014-03 To: All FHA-Approved Mortgagees
CoSign for 21CFR Part 11 Compliance
CoSign for 21CFR Part 11 Compliance 2 Electronic Signatures at Company XYZ Company XYZ operates in a regulated environment and is subject to compliance with numerous US government regulations governed
SIMATIC SIMATIC PCS 7 V8.0. Electronic Records / Electronic Signatures. Compliance Response. Answers for industry.
SIMATIC SIMATIC PCS 7 V8.0 Electronic Records / Electronic Signatures Compliance Response Edition 09/2012 Answers for industry. Compliance Response Electronic Records / Electronic Signatures for SIMATIC
Quality Manual # QS001.3. MD Logistics, Inc. (Signed copy available upon request) Prepared by Robert Grange, Director Quality
# QS001.3 MD Logistics, Inc. (Signed copy available upon request) Prepared by Robert Grange, Director Quality Date Review indicates that qualified persons from operational areas have reviewed the content
Guidance for Industry Part 11, Electronic Records; Electronic Signatures Scope and Application
Guidance for Industry Part 11, Electronic Records; Electronic Signatures Scope and Application U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research
REGULATIONS COMPLIANCE ASSESSMENT
ALIX is free software: you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation. REGULATIONS COMPLIANCE ASSESSMENT BUSINESS
Alfresco CoSign. A White Paper from Zaizi Limited. March 2013
A White Paper from Zaizi Limited March 2013 Zaizi Ltd is registered in England and Wales with the registration number 6440931. The Registered Office is 222 Westbourne Studios, 242 Acklam Road, London W10
FDA CFR PART 11 ELECTRONIC RECORDS, ELECTRONIC SIGNATURES
Document: MRM-1004-GAPCFR11 (0005) Page: 1 / 18 FDA CFR PART 11 ELECTRONIC RECORDS, ELECTRONIC SIGNATURES AUDIT TRAIL ECO # Version Change Descrition MATRIX- 449 A Ga Analysis after adding controlled documents
5 FAM 140 ACCEPTABILITY AND USE OF ELECTRONIC SIGNATURES
5 FAM 140 ACCEPTABILITY AND USE OF ELECTRONIC SIGNATURES 5 FAM 141 PURPOSE (CT-IM-112; 07-30-2010) (Office of Origin: IRM/OPS/ITI/SI/IIB) The purpose of this FAM chapter is to enable the Department to
Auditing Chromatographic Electronic Data. Jennifer Bravo, M.S. QA Manager Agilux Laboratories
Auditing Chromatographic Electronic Data Jennifer Bravo, M.S. QA Manager Agilux Laboratories Outline Raw data paper or electronic record? Controls for electronic data Auditing electronic records Warning
Sponsor Site Questionnaire FAQs Regarding Maestro Care
Sponsor Site Questionnaire FAQs Regarding Maestro Care Data Security and Validation 1. Are the electronic source documents or computer systems specific to the site and/or developed by the site? a. Developed
Comparison of FDA s Part 11 and the EU s Annex 11
Introduction The relationship between FDA s (21 CFR ) and the European Union s (EUDRALEX Rules Governing Medicinal Products in the European Union, Volume 4, Good Manufacturing Practice, Medicinal Products
Issues in Information Security and Verifiability for Biomedical Technology Companies
Ryan Morlok [email protected] Issues in Information Security and Verifiability for Biomedical Technology Companies Introduction Most people are aware of the existence of the Food and Drug Administration
Minnesota State Colleges and Universities System Procedures Chapter 5 Administration Procedures associated with Board Policy 5.22
Minnesota State Colleges and Universities System Procedures Chapter 5 Administration Procedures associated with Board Policy 5.22 5.25.1 Use of Electronic Part 1. Purpose. This procedure establishes requirements
Minnesota State Colleges and Universities System Guideline Chapter 5 Administration
Minnesota State Colleges and Universities System Guideline Chapter 5 Administration Appropriate Use and Implementation of Electronic Part 1. Purpose. To establish requirements and responsibilities for
Rackspace Archiving Compliance Overview
Rackspace Archiving Compliance Overview Freedom Information Act Sunshine Laws The federal government and nearly all state governments have established Open Records laws. The purpose of these laws is to
Guidance for electronic trial data capturing of clinical trials
Guidance for electronic trial data capturing of clinical trials 1 st November, 2007 Japan Pharmaceutical Manufacturing Association pg. 1 Table of Contents 1. Background... 3 2. Purpose... 3 3. Scope...
SUBJECT: SECURITY OF ELECTRONIC MEDICAL RECORDS COMPLIANCE WITH THE HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
UNIVERSITY OF PITTSBURGH POLICY SUBJECT: SECURITY OF ELECTRONIC MEDICAL RECORDS COMPLIANCE WITH THE HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA) DATE: March 18, 2005 I. SCOPE This
Good Documentation Practices
Good Documentation Practices Clinical Research Operations & Regulatory Support Ann Glasse, RN, BSN, MBA Director, Regulatory Support Author: Johanna Stamates, RN, MA, CCRC, CHRC Objectives Recognize the
Department of Veterans Affairs VA DIRECTIVE 6510 VA IDENTITY AND ACCESS MANAGEMENT
Department of Veterans Affairs VA DIRECTIVE 6510 Washington, DC 20420 Transmittal Sheet VA IDENTITY AND ACCESS MANAGEMENT 1. REASON FOR ISSUE: This Directive defines the policy and responsibilities to
U.S. FDA Title 21 CFR Part 11 Compliance Assessment of SAP Records Management
U.S. FDA Title 21 CFR Part 11 Compliance Assessment of SAP Records Management Disclaimer These materials are subject to change without notice. SAP AG s compliance analysis with respect to SAP software
Technical Safeguards is the third area of safeguard defined by the HIPAA Security Rule. The technical safeguards are intended to create policies and
Technical Safeguards is the third area of safeguard defined by the HIPAA Security Rule. The technical safeguards are intended to create policies and procedures to govern who has access to electronic protected
ELECTRONIC SIGNATURE REQUIREMENTS FOR LENDERS
ELECTRONIC SIGNATURE REQUIREMENTS FOR LENDERS June 2015 Purpose The Electronic Signatures in Global and National Commerce (ESIGN) Act (15 U.S.C. 7001-7006), enacted in 2000, permits, but does not require,
